We hypothesised that our analyses within the tumour microenvironment mimicked the progressive ‘endothelial-like switch’ of CD11c+ leukocytes observed in vitro, which appeared to first acquire CD34, increase CD31 expression, and progressively lose the expression of the haematopoietic marker CD45. The gene discussed is CD34; the disease is neoplasm.